Literature DB >> 10374039

Experimental models of pancreatitis.

R A al-Mufti1, R C Williamson.   

Abstract

Experimental animal models are helpful tools that have been employed to study pancreatitis for more than a century. Although not closely related to all aspects of the human disease, they have contributed greatly to our current understanding of the pathophysiology and cell biology of this disease. They have also become a standard means of testing innovative treatments against pancreatitis. This article reviews the experimental models of acute pancreatitis in common use, their severity, the criteria for the selection of an appropriate model, standards in monitoring and relevance to clinical disease. Despite their undoubted value in elucidating the mechanisms involved in the early cellular events and pathophysiology of acute pancreatitis, these models have not lent themselves to the development of effective new therapies. Models of chronic pancreatitis are also reviewed. The development of a reproducible model relevant to human chronic pancreatitis remains challenging. Experimental models of chronic pancreatitis have not yet added greatly to the understanding of the pathogenesis of this disease in man.

Entities:  

Mesh:

Year:  1999        PMID: 10374039

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  3 in total

1.  An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice.

Authors:  Jaroslaw Daniluk; Yan Liu; Defeng Deng; Jun Chu; Haojie Huang; Sebastian Gaiser; Zobeida Cruz-Monserrate; Huamin Wang; Baoan Ji; Craig D Logsdon
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  An experimental model of autoimmune pancreatitis in the rat.

Authors:  Todd S Davidson; Daniel S Longnecker; William F Hickey
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

3.  The Wistar Bonn Kobori rat, a unique animal model for autoimmune pancreatitis with extrapancreatic exocrinopathy.

Authors:  Y Sakaguchi; M Inaba; M Tsuda; G K Quan; M Omae; Y Ando; K Uchida; K Okazaki; S Ikehara
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.